Bogunia-Kubik K - Search Results

1

Soluble CD147 (BSG) as a Prognostic Marker in Multiple Myeloma.

Łacina P, Butrym A, Frontkiewicz D, Mazur G, Bogunia-Kubik K. Łacina P, et al. Curr Issues Mol Biol. 2022 Jan 14;44(1):350-359. doi: 10.3390/cimb44010026. Curr Issues Mol Biol. 2022. PMID: 35723405 Free PMC article.

2

IL-6 and IL-10 promoter gene polymorphisms do not associate with the susceptibility for multiple myeloma.

Mazur G, Bogunia-Kubik K, Wróbel T, Karabon L, Polak M, Kuliczkowski K, Lange A. Mazur G, et al. Immunol Lett. 2005 Jan 31;96(2):241-6. doi: 10.1016/j.imlet.2004.08.015. Immunol Lett. 2005. PMID: 15585329

3

Lack of association between the TNF-alpha promoter gene polymorphism and susceptibility to B-cell chronic lymphocytic leukaemia.

Bogunia-Kubik K, Mazur G, Urbanowicz I, Wróbel T, Kuliczkowski K, Woźniak M, Lange A. Bogunia-Kubik K, et al. Int J Immunogenet. 2006 Feb;33(1):21-4. doi: 10.1111/j.1744-313X.2005.00553.x. Int J Immunogenet. 2006. PMID: 16426238

4

TGF-beta1 gene polymorphisms influence the course of the disease in non-Hodgkin's lymphoma patients.

Mazur G, Bogunia-Kubik K, Wrobel T, Kuliczkowski K, Lange A. Mazur G, et al. Cytokine. 2006 Feb 7;33(3):145-9. doi: 10.1016/j.cyto.2005.12.010. Cytokine. 2006. PMID: 16524740

5

Interleukin-10 gene polymorphisms influence the clinical course of non-Hodgkin's lymphoma.

Bogunia-Kubik K, Mazur G, Wróbel T, Kuliczkowski K, Lange A. Bogunia-Kubik K, et al. Tissue Antigens. 2008 Feb;71(2):146-50. doi: 10.1111/j.1399-0039.2007.00984.x. Tissue Antigens. 2008. PMID: 18201362

6

IFN gamma gene polymorphism may contribute to the susceptibility to CLL.

Urbanowicz I, Mazur G, Stacherzak-Pawlik J, Bogunia-Kubik K, Wróbel T, Woźniak M, Kuliczkowski K. Urbanowicz I, et al. Pathol Oncol Res. 2010 Jun;16(2):213-6. doi: 10.1007/s12253-009-9209-2. Epub 2009 Sep 15. Pathol Oncol Res. 2010. PMID: 19757192 Free article.

7

VEGF and bFGF gene polymorphisms in Polish patients with B-CLL.

Wróbel T, Mazur G, Dzietczenia J, Gebura K, Kuliczkowski K, Bogunia-Kubik K. Wróbel T, et al. Med Oncol. 2013 Mar;30(1):456. doi: 10.1007/s12032-013-0456-4. Epub 2013 Jan 19. Med Oncol. 2013. PMID: 23335070 Free PMC article.

8

The CXCL12-3'A allele plays a favourable role in patients with multiple myeloma.

Mazur G, Gębura K, Gieryng A, Butrym A, Wróbel T, Bogunia-Kubik K. Mazur G, et al. Cytokine. 2013 Oct;64(1):422-6. doi: 10.1016/j.cyto.2013.05.004. Epub 2013 May 24. Cytokine. 2013. PMID: 23711392

9

VEGF and bFGF gene polymorphisms in patients with non-Hodgkin's lymphoma.

Wróbel T, Mazur G, Dzietczenia J, Gębura K, Kuliczkowski K, Bogunia-Kubik K. Wróbel T, et al. Biomed Res Int. 2013;2013:159813. doi: 10.1155/2013/159813. Epub 2013 Aug 26. Biomed Res Int. 2013. PMID: 23998120 Free PMC article.

10

IL-17F gene polymorphism is associated with susceptibility to acute myeloid leukemia.

Wróbel T, Gębura K, Wysoczańska B, Jaźwiec B, Dobrzyńska O, Mazur G, Kuliczkowski K, Bogunia-Kubik K. Wróbel T, et al. J Cancer Res Clin Oncol. 2014 Sep;140(9):1551-5. doi: 10.1007/s00432-014-1674-7. Epub 2014 May 3. J Cancer Res Clin Oncol. 2014. PMID: 24793548 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

143 results

Search Page